Treatable traits in the NOVELTY study: prevalence, patterns and relationship with physician-assessed severity
A. Agusti (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), R. Hughes (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), A. Papi (Ferrara, Italy), I. Pavord (Oxford, United Kingdom), R. Faner (Barcelona, Spain)
Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Agusti (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), R. Hughes (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), A. Papi (Ferrara, Italy), I. Pavord (Oxford, United Kingdom), R. Faner (Barcelona, Spain). Treatable traits in the NOVELTY study: prevalence, patterns and relationship with physician-assessed severity. 1289
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Insomnia in COVID-19 survivors: prevalence, severity and associated factors Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021
BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Incidence of asthma and net change in symptoms in relation to changes in obesity Source: Eur Respir J 2006 Oct 01;28(4):763-771 Year: 2006
Prevalence, incidence, and characteristics of chronic cough among adults from the canadian longitudinal study on ageing (CLSA) Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
The prevalence and symptom profile of asthma-COPD overlap: The HUNT Study Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018
Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors Source: ERJ Open Res, 4 (1) 00079-2017; 10.1183/23120541.00079-2017 Year: 2018
Prevalence of co-morbidities in Greek COPD patients in relation to the stage of the disease (COMPACT study) Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Comparison of severity of clinical, functional signs of COPD with the frequency and severity of mental disorders Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020 Year: 2021
Quality of life is associated with increased symptom burden and markers of disease severity: data from the German Bronchiectasis Registry PROGNOSIS Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018
Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Asthma prevalence and severity: an epidemiologic study in Sicily Source: Eur Respir J 2002; 20: Suppl. 38, 317s Year: 2002
Treatable traits in the NOVELTY study: assessing complexity by network analysis Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021
Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study Source: Eur Respir J 2016; 47: 482-489 Year: 2016
Relationship between respiratory symptoms (and diagnosis), anxiety or depression and smoking cigarettes: a population-based study Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002
Psychiatric disorders in patients with COPD: a population-based study on prevalence and the relationship with smoking Source: Eur Respir J 2001; 18: Suppl. 33, 192s Year: 2001
COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
Risk factors for psychological status in mild asthma: a cross-sectional survey Source: Eur Respir J 2007; 30: Suppl. 51, 615s Year: 2007
Prevalence of COPD and comorbidity Source: Eur Respir Mon 2013; 59: 1-12 Year: 2013